USS Investment Management Ltd Buys 2,218 Shares of CME Group Inc. $CME

USS Investment Management Ltd boosted its position in CME Group Inc. (NASDAQ:CME) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,117 shares of the financial services provider’s stock after purchasing an additional 2,218 shares during the period. USS Investment Management Ltd’s holdings in CME Group were worth $18,344,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the company. IFM Investors Pty Ltd raised its stake in shares of CME Group by 4.7% in the first quarter. IFM Investors Pty Ltd now owns 73,156 shares of the financial services provider’s stock valued at $21,607,000 after buying an additional 3,304 shares during the period. Premier Path Wealth Partners LLC grew its stake in shares of CME Group by 16.1% during the 1st quarter. Premier Path Wealth Partners LLC now owns 1,974 shares of the financial services provider’s stock worth $583,000 after acquiring an additional 274 shares during the period. Caliber Wealth Management LLC KS increased its holdings in CME Group by 1.1% in the 1st quarter. Caliber Wealth Management LLC KS now owns 13,060 shares of the financial services provider’s stock worth $3,857,000 after acquiring an additional 136 shares during the last quarter. Master S Wealth Management Inc. increased its holdings in CME Group by 3.4% in the 1st quarter. Master S Wealth Management Inc. now owns 1,571 shares of the financial services provider’s stock worth $464,000 after acquiring an additional 52 shares during the last quarter. Finally, Spinnaker Trust purchased a new stake in CME Group in the 1st quarter worth about $204,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

CME Group Stock Up 4.6%

CME opened at $231.00 on Thursday. The firm has a market capitalization of $83.70 billion, a P/E ratio of 19.71, a price-to-earnings-growth ratio of 2.47 and a beta of 0.21. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a fifty day moving average price of $269.11 and a 200-day moving average price of $284.88. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the company earned $2.80 earnings per share. Equities research analysts expect that CME Group Inc. will post 12.28 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.3%. CME Group’s payout ratio is presently 44.37%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CME shares. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price for the company in a research report on Thursday, June 18th. UBS Group reissued an “overweight” rating on shares of CME Group in a research report on Monday, June 15th. Jefferies Financial Group dropped their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley cut their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a report on Thursday, April 23rd. Finally, TD Cowen lowered their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, CME Group currently has an average rating of “Moderate Buy” and an average target price of $300.94.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Keefe, Bruyette & Woods upgraded CME Group (CME) to Outperform from Market Perform and kept a $305 price target, citing an attractive risk/reward setup after recent stock weakness. Article Title
• Positive Sentiment: Insider buying may also support sentiment: Director William Shepard bought 325 shares at about $230.57 per share, signaling confidence from management. Article Title
• Positive Sentiment: Analysts still expect modest earnings growth ahead of CME’s next report, and one note lifted FY2027 EPS estimates slightly, reinforcing the view that fundamentals remain solid. Article Title
• Neutral Sentiment: CME is expected to report second-quarter results soon, with Wall Street looking for low-single-digit profit growth; investors may be waiting for the print before making bigger moves. Article Title
• Negative Sentiment: Goldman Sachs cut its price target on CME Group (CME) to $245 from $267 and maintained a Sell rating, which likely weighed on the stock. Article Title
• Negative Sentiment: DraftKings’ move to bring its prediction-markets infrastructure in-house may reduce reliance on third-party platforms such as CME over time, creating a potential competitive headwind. Article Title

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.